middle east and africa autotransfusion devices Market

The Middle East & Africa autotransfusion devices market is expected to reach US$ 55.53 million by 2027 from US$ 43.82 million in 2019; it is anticipated to grow at a CAGR of 3.1% from 2020 to 2027.

The Middle East & Africa autotransfusion devices market growth is attributed to the involvement of rare blood groups, surge in the adoption of transplant procedures, and increase in prevalence of chronic diseases. However, risks associated with autotransfusion restrain the growth of the market.

Cancer, cardiovascular diseases, and renal disorders are a few of the major deadly diseases. The treatment of these types of conditions involves surgical procedures; wherein the patient may lose excessive volume of blood. According to the Cancer Association of South Africa (CANSA), nearly 100,000 South Africans get diagnosed with cancer annually. In cancer treatment, a patient undergoes various surgical procedures that include the removal of tumors and organs, leading to excessive blood loss. The blood loss is compensated by the infusion of fresh blood or reinfusion of the patient’s blood with the help of autotransfusion devices. Thus, the Middle East & Africa autotransfusion devices market is growing owing to the increase in surgical procedures due to the rising incidence of chronic diseases.

Amid the COVID-19 pandemic, lockdown restrictions are restricting the demand for autotransfusion devices. Now pharma companies are developing strategies to regularize the supply chain and meet the demands from end users. Also, the demand for autotransfusion devices in the region is expected to increase during the coming months owing to the reopening of hospitals and surgical centers for regular surgical procedures, which was postponed in the lockdown period.

Based on type, the Middle East & Africa autotransfusion devices market is bifurcated into products and accessories. The products segment held a larger share of the market in 2019. However, the accessories segment is estimated to register a higher CAGR in the market during the forecast period.

The Middle East & Africa autotransfusion devices market, by application, is segmented into cardiac surgeries, orthopaedic surgeries, organ transplantation, trauma procedures, and others. The cardiac surgeries segment held the largest market share in 2019, whereas the organ transplantation segment is estimated to register the highest CAGR in the market during 2020–2027.

Based on end user, the autotransfusion devices market in Middle East & Africa is segmented into hospitals, specialty clinics, and ambulatory surgical centers. The hospitals segment held the largest share of the market in 2019, and it is expected to register the highest CAGR in the market from 2020 to 2027.

A few of the primary and secondary sources referred to while preparing this report on the Middle East & Africa autotransfusion devices market are the World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), and American Health Association.